Literature DB >> 17167772

Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis.

Aurélien Olichon1, Thomas Landes, Laetitia Arnauné-Pelloquin, Laurent J Emorine, Valérie Mils, Agnès Guichet, Cécile Delettre, Christian Hamel, Patrizia Amati-Bonneau, Dominique Bonneau, Pascal Reynier, Guy Lenaers, Pascale Belenguer.   

Abstract

To characterize the molecular links between type-1 autosomal dominant optic atrophy (ADOA) and OPA1 dysfunctions, the effects of pathogenic alleles of this dynamin on mitochondrial morphology and apoptosis were analyzed, either in fibroblasts from affected individuals, or in HeLa cells transfected with similar mutants. The alleles were missense substitutions in the GTPase domain (OPA1(G300E) and OPA1(R290Q)) or deletion of the GTPase effector domain (OPA1(Delta58)). Fragmentation of mitochondria and apoptosis increased in OPA1(R290Q) fibroblasts and in OPA1(G300E) transfected HeLa cells. OPA1(Delta58) did not influence mitochondrial morphology, but increased the sensitivity to staurosporine of fibroblasts. In these cells, the amount of OPA1 protein was half of that in control fibroblasts. We conclude that GTPase mutants exert a dominant negative effect by competing with wild-type alleles to integrate into fusion-competent complexes, whereas C-terminal truncated alleles act by haplo-insufficiency. We present a model where antagonistic fusion and fission forces maintain the mitochondrial network, within morphological limits that are compatible with cellular functions. In the retinal ganglion cells (RGCs) of patients suffering from type-1 ADOA, OPA1-driven fusion cannot adequately oppose fission, thereby rendering them more sensitive to apoptotic stimuli and eventually leading to optic nerve degeneration. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17167772     DOI: 10.1002/jcp.20950

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  52 in total

1.  OPA1 mutations in Japanese patients suspected to have autosomal dominant optic atrophy.

Authors:  Tetsuya Hamahata; Takuro Fujimaki; Keiko Fujiki; Ai Miyazaki; Atsushi Mizota; Akira Murakami
Journal:  Jpn J Ophthalmol       Date:  2011-11-01       Impact factor: 2.447

2.  The BH3-only Bnip3 binds to the dynamin Opa1 to promote mitochondrial fragmentation and apoptosis by distinct mechanisms.

Authors:  Thomas Landes; Laurent J Emorine; Delphine Courilleau; Manuel Rojo; Pascale Belenguer; Laetitia Arnauné-Pelloquin
Journal:  EMBO Rep       Date:  2010-04-30       Impact factor: 8.807

Review 3.  Dominant optic atrophy.

Authors:  Guy Lenaers; Christian Hamel; Cécile Delettre; Patrizia Amati-Bonneau; Vincent Procaccio; Dominique Bonneau; Pascal Reynier; Dan Milea
Journal:  Orphanet J Rare Dis       Date:  2012-07-09       Impact factor: 4.123

4.  The OPA1 Gene Mutations Are Frequent in Han Chinese Patients with Suspected Optic Neuropathy.

Authors:  A-Mei Zhang; Rui Bi; Qiu-Xiang Hu; Yu Fan; Qingjiong Zhang; Yong-Gang Yao
Journal:  Mol Neurobiol       Date:  2016-02-11       Impact factor: 5.590

5.  Caspases indirectly regulate cleavage of the mitochondrial fusion GTPase OPA1 in neurons undergoing apoptosis.

Authors:  F Alexandra Loucks; Emily K Schroeder; Amelia E Zommer; Shea Hilger; Natalie A Kelsey; Ron J Bouchard; Craig Blackstone; Jay L Brewster; Daniel A Linseman
Journal:  Brain Res       Date:  2008-11-18       Impact factor: 3.252

6.  SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress.

Authors:  Sadhana A Samant; Hannah J Zhang; Zhigang Hong; Vinodkumar B Pillai; Nagalingam R Sundaresan; Donald Wolfgeher; Stephen L Archer; David C Chan; Mahesh P Gupta
Journal:  Mol Cell Biol       Date:  2013-12-16       Impact factor: 4.272

Review 7.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

8.  Altered skeletal muscle mitochondrial biogenesis but improved endurance capacity in trained OPA1-deficient mice.

Authors:  F Caffin; A Prola; J Piquereau; M Novotova; D J David; A Garnier; D Fortin; M V Alavi; V Veksler; R Ventura-Clapier; F Joubert
Journal:  J Physiol       Date:  2013-09-16       Impact factor: 5.182

9.  Solving a 50 year mystery of a missing OPA1 mutation: more insights from the first family diagnosed with autosomal dominant optic atrophy.

Authors:  Nico Fuhrmann; Simone Schimpf; York Kamenisch; Beate Leo-Kottler; Christiane Alexander; Georg Auburger; Eberhart Zrenner; Bernd Wissinger; Marcel V Alavi
Journal:  Mol Neurodegener       Date:  2010-06-14       Impact factor: 14.195

10.  Heterozygous mutation of Opa1 in Drosophila shortens lifespan mediated through increased reactive oxygen species production.

Authors:  Sha Tang; Phung Khanh Le; Stephanie Tse; Douglas C Wallace; Taosheng Huang
Journal:  PLoS One       Date:  2009-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.